Journal of Thyroid Research

Journal of Thyroid Research / 2016 / Article

Corrigendum | Open Access

Volume 2016 |Article ID 2168046 | 1 page | https://doi.org/10.1155/2016/2168046

Corrigendum to “How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer”

Received14 Mar 2016
Accepted25 May 2016
Published28 Jun 2016

In the article titled “How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer” [1], the following sentence should be added to the “Acknowledgments” section: This work was also supported by FEDER funds through Programa Operacional Factores de Competitividade (COMPETE) (FCOMP-01-0124-FEDER 011267).

References

  1. H. Prazeres, J. Torres, F. Rodrigues et al., “How to treat a signal? Current basis for RET-genotype-oriented choice of kinase inhibitors for the treatment of medullary thyroid cancer,” Journal of Thyroid Research, vol. 2011, Article ID 678357, 10 pages, 2011. View at: Publisher Site | Google Scholar

Copyright © 2016 Hugo Prazeres et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

672 Views | 266 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.